ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,618.26
      -0.29%
      US Tech 100
      18,909.66
      -0.16%
      Dow Jones
      41,503.10
      -0.25%
      Brent Oil
      72.475
      -1.15%
      Bitcoin
      60,142.04
      -0.26%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Caladrius Biosciences Inc (CLBS) Quote

      Caladrius Biosciences Inc

      Caladrius Biosciences Inc (CLBS)

      Celebrus Technologies Plc
      0.4264
      0.00
      (0.00%)
      At close: September 18 4:00PM
      Delayed by 15 minutes
      0.4264
      0.00
      ( 0.00% )
      After Hours: -
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      0.4264
      Bid
      0.4264
      Ask
      0.43
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      3.475M
      Previous Close
      0.4264
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      8,150,000
      Dividend Yield
      -
      PE Ratio
      -1.22
      Earnings Per Share (EPS)
      -2.56
      Revenue
      -
      Net Profit
      -20.84M

      About Caladrius Biosciences Inc

      Caladrius Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to the development of treatments and reversal of severe diseases. The company is developing first-in-class therapeutics based on the characteristics of naturally occurring CD34+ cells and their ability to stimulate the... Caladrius Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to the development of treatments and reversal of severe diseases. The company is developing first-in-class therapeutics based on the characteristics of naturally occurring CD34+ cells and their ability to stimulate the growth of new microvasculature. Its current product candidates include XOWNA, HONEDRA and CLBS201. Show more

      Sector
      Health & Allied Services,nec
      Industry
      Insurance Carriers, Nec
      Website
      www.caladrius.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      2006

      Ask ADVFN Intelligence (AI)

      CLBS Latest News

      More News

      FeaturedElement79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership

      6 hours ago

      Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics

      Company to commence trading on The Nasdaq Capital Market under Ticker Symbol “LSTA” Lisata has approximately $76 million in cash and investments following transaction close Lisata strengthens...

      September 15 2022
      GlobeNewswire Inc.

      Caladrius Biosciences Announces Approval of Merger and Name Change to Lisata Therapeutics

      BASKING RIDGE, N.J., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), announced today that, based upon the final vote count certified...

      September 14 2022
      GlobeNewswire Inc.

      Life Sciences Virtual Investor Conference Agenda Announced for September 15th

      NEW YORK, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the upcoming Life Sciences Virtual...

      September 12 2022
      GlobeNewswire Inc.

      Caladrius Biosciences Announces Participation in Upcoming Investor Conferences in September 2022

      BASKING RIDGE, N.J., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company developing...

      September 08 2022
      GlobeNewswire Inc.

      Caladrius Biosciences’ Prospective Merger Partner, Cend Therapeutics, Announces Collaboration Agreement with Roche to Evaluate CEND-1 in Combination with Immunotherapy to Treat Pancreatic Cancer

      Study to be part of Roche’s Morpheus Platform designed to enable more rapid and efficient development of novel cancer immunotherapy combinations Agreement accelerated by Caladrius’ initial...

      August 10 2022
      GlobeNewswire Inc.

      Caladrius Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update

      Merger with Cend Therapeutics remains on track to close in the third quarter of 2022, subject to stockholder approval, resulting in the formation of Lisata Therapeutics Conference call begins...

      August 04 2022
      GlobeNewswire Inc.

      Caladrius Biosciences Completes Enrollment in Phase 1b Study of CLBS201 for the Treatment of Diabetic Kidney Disease

      BASKING RIDGE, N.J., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company developing innovative...

      August 02 2022
      GlobeNewswire Inc.

      Caladrius Biosciences to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 4, 2022, at 4:30 p.m. Eastern Time

      BASKING RIDGE, N.J., July 28, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company developing innovative...

      July 28 2022
      GlobeNewswire Inc.

      Caladrius Biosciences and Cend Therapeutics Announce Publication of Pancreatic Cancer Trial Data in The Lancet Gastroenterology and Hepatology

      BASKING RIDGE, N.J. and SAN DIEGO, July 06, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company...

      July 06 2022
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      XCURExicure Inc
      $ 4.95
      (110.64%)
      		2.51M
      VEROVenus Concept Inc
      $ 0.722
      (43.68%)
      		3.6M
      ZEOZeo Energy Corporation
      $ 1.46
      (28.07%)
      		1.09k
      EPIXESSA Pharma Inc
      $ 6.91
      (15.36%)
      		14.25k
      INDPIndaptus Therapeutics Inc
      $ 1.60
      (11.89%)
      		682
      SMFLSmart for Life Inc
      $ 0.493
      (-36.80%)
      		966.56k
      CRMTAmericas Car Mart Inc
      $ 45.01
      (-10.25%)
      		4.14k
      SMSISmith Micro Software Inc
      $ 0.9102
      (-9.77%)
      		79.95k
      MYPSPLAYSTUDIOS Inc
      $ 1.50
      (-8.81%)
      		1.45M
      NUZENuZee Inc
      $ 0.9757
      (-7.08%)
      		7.54k
      NVDANVIDIA Corporation
      $ 113.54
      (0.12%)
      		4.52M
      VEROVenus Concept Inc
      $ 0.722
      (43.68%)
      		3.6M
      XCURExicure Inc
      $ 4.80
      (104.26%)
      		2.51M
      EJHE Home Household Service Holdings Ltd
      $ 0.101
      (-1.66%)
      		1.95M
      ANNXAnnexon Inc
      $ 6.93
      (0.29%)
      		1.81M

      Discussion

      View Full Feed
      Carjockey2 Carjockey2 44 seconds ago
      Flight to Florida at 3:30 on Friday...

      I'll figure something out.
      AAPJ
      Maria56 Maria56 53 seconds ago
      By "this" do you mean "hot"?
      moves on this air…!

      mONI
      MONI
      Jack_Bolander Jack_Bolander 1 minute ago
      WTM - Please let me add :
      - Liquide Hydrogen plants are more complex and more expensive . Cryogenics take more time and money as we found out in Georgia.
      - High Pressure Hydrogen Storage is more dangerous 700-900+ BAR (10,000+ PSI)
      - Linde Invented the Liquefication Process fo
      PLUG
      CommodityCoverage CommodityCoverage 1 minute ago
      With two key assets in Mexico, the producing Campo Morado and near-term producing Tahuehueto, LUCA Mining (LUCA.v, LUCMF) is a junior gold and base metals producer on track to produce 100,000 gold equivalent ounces by 2025 and provides a natural hedge with gold, copper, silver, zinc, and lead amid
      LUCMF
      Biotechotcguy Biotechotcguy 2 minutes ago
      Yeah maybe ask the FDA too.
      DROR
      Pyramid2 Pyramid2 2 minutes ago
      XCUR over $6.5
      XCUR
      PopsT PopsT 2 minutes ago
      Will wait and see................................ LOL
      ERHE
      Carjockey2 Carjockey2 2 minutes ago
      Especially after the last 2 days being up massively.

      >>>Up 22% on the day, not too shabby.
      TGRP
      MDA MDA 2 minutes ago
      I for one hope you are absolutely right

      I have 15M shares, I would make $1500 per point. I had 6M shares and 2 tickers and saw my account go 10K, 20K 30, then boost 60K per day!!!!!

      Then I saw one stock bring me up $120 and then 30 minutes later I was down $80K on the
      RNVA
      gimmee greenbacks gimmee greenbacks 2 minutes ago
      Looks like Biel farmed that out to domestic distributors who are doing a fantastic job.

      Smart move and should reap rewards soon imo..



      BIEL
      BIEL
      Ecomike Ecomike 2 minutes ago
      The shorts on IFUS sound crazy-desperate, like kids that got their candy taken away paying the piper $$$$$ for the short sighted shorts they can not cover with out going broke. As Spock's father Surek once said "Lessons are often Expensive"
      IFUS
      surfkast surfkast 2 minutes ago
      Good old George is getting crushed from all angles. Three stocks crashed big time today. Blood bath coming to a theater near you.
      WNFT
      uplata uplata 3 minutes ago
      It was perfect sell the news.. it was expected..

      Got long eod coin avgo tsla all call side..stop today's low..
      theorysuit theorysuit 3 minutes ago
      They don't have much left to dilute. Look for a reverse split with a new batch of authorized or perhaps they fold and private Advent "buys" NWBO's IP.

      You are absolutely right. They need more authorized shares to dilute......in 3 2 1.
      NWBO
      santafe2 santafe2 4 minutes ago
      CNN has made a career of being useless. They're screaming that this is a "huge" rate cut. Republicans will call it biased. Anyone watching the futures knew there was better than a 50/50 chance this would be the size of the cut. Since the market expected it, there's a lot of smart money taking profit
      Pyramid2 Pyramid2 4 minutes ago
      XCUR on drugs

      $4.01 entry out over 5 ah on 10,000 Clay like 3min did not time it.

      https://elite.finviz.com/published_idea.ashx?t=XCUR&f=091824&i=XCURi5163800988i

      Your lounge rules state:

      1. Do not talk about politics
      2. Do not talk a
      XCUR
      blackhawks blackhawks 4 minutes ago
      Statement from Vice President Harris on the Federal Reserve’s announcement

      https://x.com/KamalaHQ/status/1836497634082603258?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1836497634082603258%7Ctwgr%5E5f91330d0764295a6eaed972a7b667ff583a34f3%7Ctwcon%5Es1_&ref_url=https%3A%2F%2Fw
      Spuds McKenz66 Spuds McKenz66 4 minutes ago
      leaked? they were bragging about making acquisitions, like I will bang you later bye lol a tease broad , unless its time to load the boat op?
      SMFL
      Buckey Buckey 4 minutes ago
      OMEX tanked 90% yesterday on Ch 11 I think big 200% bounce today
      OMEX
      Acme Investments Acme Investments 4 minutes ago
      Getting older 🧓 every day!! Looks like this ticker is going to take a long time!!
      HIRU
      prussian4profit prussian4profit 4 minutes ago
      "LOL! Maybe because I point out the FACTUAL..."

      Again, another long winding post from someone who believes phantom limb pain is fake. Consider the source.

      The military community has taken notice. It's coming.
      BIEL
      surfkast surfkast 5 minutes ago
      The comedy show continues while GS stocks are beginning a major sell off. Clown will not accomplish anything of value.
      SRNW
      blackhawks blackhawks 5 minutes ago
      Statement from Vice President Harris on the Federal Reserve’s announcement

      https://x.com/KamalaHQ/status/1836497634082603258?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1836497634082603258%7Ctwgr%5E5f91330d0764295a6eaed972a7b667ff583a34f3%7Ctwcon%5Es1_&ref_url=https%3A%2F%2Fw
      Longer Than Most Longer Than Most 5 minutes ago
      That is big
      ICTY

      Your Recent History

      NASDAQ
      CLBS
      Caladrius Biosciences
      Delayed Upgrade Clock